Carol Y. Suh - Net Worth and Insider Trading

Carol Y. Suh Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Carol Y. Suh owns 1 companies in total, including Neumora Therapeutics Inc (NMRA) .

Click here to see the complete history of Carol Y. Suh’s form 4 insider trades.

Insider Ownership Summary of Carol Y. Suh

Ticker	Comapny	Transaction Date	Type of Owner
NMRA	Neumora Therapeutics Inc	2023-09-14	Chief Operating Officer

Carol Y. Suh Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Carol Y. Suh Ownership Network

Ownership Network List of Carol Y. Suh

No Data

Ownership Network Relation of Carol Y. Suh

Carol Y. Suh Owned Company Details

What does Neumora Therapeutics Inc do?

Who are the key executives at Neumora Therapeutics Inc?

Carol Y. Suh is the Chief Operating Officer of Neumora Therapeutics Inc. Other key executives at Neumora Therapeutics Inc include Head of R&D Robert A. Lenz , Chief Financial Officer Joshua Pinto , and 10 percent owner Arch Venture Partners Xii, Llc .

Neumora Therapeutics Inc (NMRA) Insider Trades Summary

Over the past 18 months, Carol Y. Suh made no insider transaction in Neumora Therapeutics Inc (NMRA). Other recent insider transactions involving Neumora Therapeutics Inc (NMRA) include a net purchase of 2,007,064 shares made by Kristina Burow , a net purchase of 507,064 shares made by Arch Venture Partners Xii, Llc , and a net sale of 100,000 shares made by Joshua Pinto .

In summary, during the past 3 months, insiders sold 174,412 shares of Neumora Therapeutics Inc (NMRA) in total and bought 0 shares, with a net sale of 174,412 shares. During the past 18 months, 174,412 shares of Neumora Therapeutics Inc (NMRA) were sold and 7,293,833 shares were bought by its insiders, resulting in a net purchase of 7,119,421 shares.

Neumora Therapeutics Inc (NMRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neumora Therapeutics Inc Insider Transactions

No Available Data

Carol Y. Suh Mailing Address

Above is the net worth, insider trading, and ownership report for Carol Y. Suh. You might contact Carol Y. Suh via mailing address: C/o Neumora Therapeutics, Inc., 490 Arsenal Way, Suite 200, Watertown Ma 02472.

Discussions on Carol Y. Suh

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.